Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000165295 | SCV000216014 | likely benign | Hereditary cancer-predisposing syndrome | 2016-02-24 | criteria provided, single submitter | clinical testing | In silico models in agreement (benign);Insufficient or conflicting evidence |
Labcorp Genetics |
RCV000555601 | SCV000628726 | likely benign | Neurofibromatosis, type 1 | 2024-11-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000681221 | SCV000808681 | likely benign | not provided | 2018-04-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV002362858 | SCV002663232 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2020-03-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Genomic Medicine, |
RCV002465550 | SCV002760911 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000681221 | SCV005624679 | uncertain significance | not provided | 2024-02-13 | criteria provided, single submitter | clinical testing |